EMERALD MUTUAL FUND ADVISERS TRUST - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 155 filers reported holding NPS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
EMERALD MUTUAL FUND ADVISERS TRUST ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$9,931,000
-2.4%
277,633
-29.0%
0.86%
-11.6%
Q3 2014$10,173,000
+39.1%
391,281
+76.8%
0.98%
+44.9%
Q2 2014$7,316,000
-38.1%
221,362
-44.0%
0.67%
-40.5%
Q1 2014$11,827,000
-46.6%
395,168
-39.8%
1.13%
-14.4%
Q4 2013$22,133,000
-48.8%
656,826
-51.7%
1.32%
-55.8%
Q3 2013$43,248,000
+376.7%
1,359,602
+126.4%
2.99%
+94.4%
Q2 2013$9,073,000600,4711.54%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 549,425$16,680,0006.89%
Opaleye Management Inc. 205,000$5,945,000,0004.67%
Rhenman & Partners Asset Management AB 240,000$7,286,0002.85%
SECTORAL ASSET MANAGEMENT INC 1,774,919$53,887,0002.32%
Eventide Asset Management 242,700$7,368,0002.27%
OAK RIDGE INVESTMENTS LLC 2,713,717$82,389,0002.16%
First Light Asset Management, LLC 68,245$2,072,0001.76%
Broadfin Capital, LLC 400,000$12,144,0001.60%
Cupps Capital Management, LLC 748,175$22,714,0001.54%
FCG ADVISORS, LLC 70,651$2,145,0001.45%
View complete list of NPS PHARMACEUTICALS INC shareholders